Hangzhou AGS Medtech(688581.SH) granted 391,500 restricted shares at a price of 70 yuan per share.
Hangzhou AGS Medtech(688581.SH) announcement, the restrictive stock grant conditions stipulated in the company's 2023 restricted stock incentive plan have been achieved. The company has determined September 7, 2023 as the initial grant date for the restricted stocks of this equity incentive plan. It will grant 391,500 restricted stocks at a price of 70 yuan per share to 69 eligible incentive recipients.
Related Articles

Ford (F.US) leverages AI to deeply mine the commercial vehicle gold mine: Monitoring 1 billion data points, aiming to digitize fleet management.

GMTEight List of A-share restricted sales and lifting restrictions | March 11th

Hong Kong stocks concept tracking | Traffic in the Hormuz Strait is obstructed by the REFIRE pattern, oil transportation leading companies benefit from rising freight rates (with concept stocks)
Ford (F.US) leverages AI to deeply mine the commercial vehicle gold mine: Monitoring 1 billion data points, aiming to digitize fleet management.

GMTEight List of A-share restricted sales and lifting restrictions | March 11th

Hong Kong stocks concept tracking | Traffic in the Hormuz Strait is obstructed by the REFIRE pattern, oil transportation leading companies benefit from rising freight rates (with concept stocks)

RECOMMEND

Local Policies Experiment With “Lobster” AI Agents Accelerate Into The Agent Era But Security Risks Remain
10/03/2026

Hong Kong And Macau Join Billion‑Level Guidance Fund Initiative Hong Kong Sets Return‑Investment KPI Macau Targets MOP 20 Billion
10/03/2026

Southbound Capital Sells Heavily Yet Hang Seng Tech Advances How Do Fund Managers Interpret It
10/03/2026


